Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-29
2005-03-29
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S199000
Reexamination Certificate
active
06872733
ABSTRACT:
Disclosed are compounds of the formula (I):wherein A, B, C, M1-M4, R, R1, R2and n are as described herein.
REFERENCES:
patent: 3161645 (1964-12-01), Adriaan et al.
patent: 3318900 (1967-05-01), Adriaan et al.
patent: 3325499 (1967-06-01), Poos et al.
patent: 4215119 (1980-07-01), Mentrup et al.
patent: 4329353 (1982-05-01), Stokbroekx et al.
patent: 4410528 (1983-10-01), Teranishi et al.
patent: 5574044 (1996-11-01), Thompson et al.
patent: 5661169 (1997-08-01), Di Malta et al.
patent: 5760054 (1998-06-01), Huff et al.
patent: 5767118 (1998-06-01), Nargund et al.
patent: 6063796 (2000-05-01), Yang et al.
patent: 6166037 (2000-12-01), Budhu et al.
patent: 6172067 (2001-01-01), Ito et al.
patent: 0092391 (1983-10-01), None
patent: 0921125 (1999-06-01), None
patent: 60120872 (1985-06-01), None
patent: 10330377 (1998-12-01), None
patent: 9710213 (1997-03-01), None
patent: 9740035 (1997-10-01), None
patent: 9854168 (1998-12-01), None
patent: 9929696 (1999-06-01), None
patent: 9936421 (1999-07-01), None
patent: 9948492 (1999-09-01), None
patent: 9959997 (1999-11-01), None
patent: 0006545 (2000-02-01), None
patent: 0107050 (2001-02-01), None
patent: 0144213 (2001-06-01), None
patent: 0220011 (2002-03-01), None
Gross et al. “Preparation of 4-benzimidazol . . . ” CA 138:368892 (2003).*
Kyle et al. “Preparation of benzimidazol-2-one having . . . ” CA 135:138290 (2000).*
Tulshian et al. “Preparation of piperidine derivatives . . . ” CA 132:137290 (2000).*
Ciba-Geigy et al. “Preparation of 4-aminoalkyl-4H,6H-pyrrolo . . . ” CA 108:186778 (1988).*
Ternaishi et al. “Piperidine derivatives and pharmaceutical . . . ” CA 95:132947 (1981).*
Custers, F.G.J., “Vesamicol and some of its derivatives: Questionable ligands for selectively labelling acetylcholine transporters in rat brain”,European Journal of Pharmacology, 338: 117-183, 1997.
Harrison T, et al., “High Affinity, Selective Neurokinin 2 and Neurokinin 3 Receptor Antagonists from a Common Structural Template,”Bioorganic&Medicinal Chemistry Letters., vol. 8, pp 1343-1348, especially compounds 2d and 3d on p. 1345. (1998).
Takai H, et al., Synthesis and Pharmacological Evaluation of Peperidine Derivatives with Various Heterocyclic Rings at the 4-Position, Chemical Pharmaceutical Bulletin, Mar. 1985, vol. 33, No. 3, pp. 1105-1115, especially pp. 1105 and 1106.
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 129:54361, Huff, et al., ‘Preparation of benzisothiazolones and analogs as alpha. 1C. adrenergic receptor antagonist’, 1998, 392146 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 130:95479, Sasaki, et al., ‘Preparation of piperidine derivatives as cell adhesion inhibitors for inflammation inhibitors, metastasis inhibitors etc.’, 1998, 795478 CAPLUS (Abstract).
Database on STN CADATA (Columbus, Ohio, USA) CA accession: No. 124:176079, Huff, et al., ‘Preparation of heterocycles as alpha-1c adrenergic receptor antagonists’, 1995, 998362 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 81:77786, Klein, et al., ‘Potential analgesics. 3. 1-(4-Piperidinyl) -2-indolinones and -3, 4-dihydrocarbostyrils’,Arch. Pharm. vol. 307 (5), pp 360-365. (1974), 1974, 47786 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 136:53656, Forbes I.T., ‘A short and efficient syntheisis of N-substituted indol-2-ones (oxindoles)’,Tetrahedron Let., (2001), vol. 42 (39), pp. 6943-6945, 2001:674545 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 135:195564, Tsushima, et al., ‘Preparation of phenoxalkylamine derivatives useful as opioid delta receptor agonists’, WO 2001/60796 (2001), 2001, 617978 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 135:272955, Tsushima, et al., ‘Preparation of diphenylalkylpiperidine derivatives useful as opioid delta receptor agoinsts’, 2001:713309 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 130:223167, Budhu, et al., ‘Preparation of piperidinylpyrrolidins as modulators of chemokine receptor activity’, 1999:172595 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 95:203828, Bianchi, et al., ‘Compounds with antiulcer and antisecretory activity. I. 3-Aryl-benzimidazolin-2-ones and -thiones’,Eur. J. Med. Chem, 16(4), pp. 321-326 (1981), 1981:203828 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 73:445405, Ogata, et al., ‘Organic photochemical reactions. VII. Photolysis of 1-benzyl-2-ethylbenzimidazole 3-oxide’,Chem. Pharm. Bull, 18(5), pp. 964-969. (1970), 1970:445405 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 95:177993, Guiliano, et al., ‘Spectroscopic studies of 2-oxo-2, 3-dihydrobenzimidazole and some N-monosubstituted o r N,N' -disubstituted derivatives’,App. Spectrosc., (1981), 35(5), pp. 486-488, 1981:577993 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio, USA) CA accession: No. 134:353434, Nakamura, et al., ‘Synthesis of a regio-isomer of kealiiquinone, a marine benzimidazole alkaloid’,J. Chem. Soc. Japan, (2001), (4), pp. 429-436, 2001:112633 CAPLUS (Abstract).
Database on STN CASDATA (Columbus, Ohio) CA accession: No. 125:58298, Suzuki, et al., ‘Preparation of hetererocycle-containing amides as 5-HT4 agonists’, PCT Int. Appl., p. 122 (WO 96/05166), 1996: 393911 CAPLUS (Abstract).
Chen Zhengming
Goehring R. Richard
Kyle Donald
Victory Sam
Chang Celia
Euro-Celtique S.A.
Koller Alan L.
Sand Stephen J.
Strassburger Phillip C.
LandOfFree
Benzimidazolone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazolone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazolone compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3411867